// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Assessing proteoglycans and proteoglycanases as biomarkers for thoracic aortic aneurysms

Marsioleda Kemberi - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

guanidine

An epigenomic investigation of atrial fibrillation in a paired left and right atrial cohort

Adrian Rodriguez - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Identifying older donor hearts suitable for transplantation: the use of senescence as a marker of biological age.

Maria Camacho Encina - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Sulfasalazine

Design of the blood flow path for the neovad: an implantable ventricular assist device for infants

Katharine Fraser - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibition of phlpp phosphatases reduces vascular smooth muscle cell calcification

Samantha Borland - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Calcified vascular disease

Prostratin

RNA binding protein multiple splicing (RBPMS) drives a contractile splicing network in human embryonic stem cell derived vascular smooth muscle cells.

Aishwarya Jacob - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Angiology

Calcified vascular disease

Doxycycline

A clinician-led understanding of the implementation of digital technologies within heart disease diagnosis: a qualitative investigation

Kamilla Abdullayev - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibition of RHO KINASE2 is associated with vasorelaxation but not reduction in myocardial contractility

Lucie Pearce - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Isoflurane

Using overset meshing and blended weak-strong coupling results in accurate and efficient models of a positive-displacement artificial heart

Joseph Bornoff - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Pyroptosis may not contribute to anthracycline doxorubicin and its metabolite doxorubicinol cytotoxicity in coronary artery endothelial cells

Handi Salim - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute myelocytic leukemia

Doxorubicin

Extracellular vesicles initiate hydroxyapatite formation which precedes vascular smooth muscle cell osteogenic differentiation

Meredith Whitehead - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

‘Cardiac organoids. A model to investigate the effect of diabetes on cardiac development and function’

Magdalini Eleftheriadou - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

T cell responses driving inflammatory mechanisms in paediatric congenital heart disease graft rjection

Francesca Bartoli-Leonard - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital heart disease

N/A

Rapid quantification of diffuse cardiac fibrosis using microct in mice

Emily Lupton - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac fibrosis

Omnipaque

A phylogenetic modelling approach to identify evolutionary shifts in tissue-specific enhancers - application to the mole-rat clade

Diego Villar - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Solid malignancies

N/A

BCL-6B is a novel regulator of hipsc-based vascular cell lineage specification

Chenxin Liu - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

B cell lymphomas

N/A

Investigating the therapeutic potential of recombinant bmp10 in a mouse model of hereditary haemorrhagic telangiectasia

Karolina Kostrzynska - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tamoxifen

Lineage-specific phenotypic abnormalities in IPSC-derived smooth muscle cells from type 1 loeys-dietz syndrome

Franklin Lo - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Loeys Dietz syndrome

stannous fluoride

Accuracy of machine learning techniques to predict stress echocardiography results using clinical variables.

Ugochukwu Ihekwaba - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

N/A

Characterisation of chemokine receptors in CD4+CD28NULL T lymphocytes from patients with acute coronary syndrome

Danielle Lezama - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Copyright © 2026. QuantiNova All rights reserved